Rely to: 'Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment: Methodological issues'

被引：0
|
作者：
Tao, Ya-Chao [1 ,2 ]
Chen, En-Qiang [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, Div Infect Dis, State Key Lab Biotherapy, Chengdu, Peoples R China
来源：
JOURNAL OF VIRAL HEPATITIS | 2021年 / 28卷 / 01期
关键词：
D O I：
10.1111/jvh.13390
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：221 / 222
页数：2
相关论文
共 50 条
  • [41] Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective study
    Boglione, Lucio
    De Benedetto, Ilaria
    Lupia, Tommaso
    Cusato, Jessica
    Cariti, Giuseppe
    Di Perri, Giovanni
    [J]. ARCHIVES OF VIROLOGY, 2021, 166 (04) : 1125 - 1131
  • [42] Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naive patients with a partial virological response (vol 201, pg 443, 2011)
    Zoutendijk, R.
    [J]. HEPATOLOGY, 2011, 54 (06) : 2280 - 2281
  • [43] SAFETY AND EFFICACY OF SWITCHING ENTECAVIR TO TENOFOVIR VERSUS TENOFOVIR TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B: A COMPARATIVE STUDY
    Ungtrakul, Teerapat
    Dechma, Jiraporn
    Chunnuan, Pitchayachuda
    Kusuman, Pattama
    Pothijaroen, Charinthip
    Tawpa, Jantarika
    Pongpun, Wanwisa
    Soonklang, Kamonwan
    Sriprayoon, Tassanee
    Tanwandee, Tawesak
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S1135 - S1135
  • [44] Efficacy of entecavir switch therapy in chronic hepatitis B patients with incomplete virological response to telbivudine
    Lo, Angeline Oi-Shan
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    Chan, Hoi-Yun
    Cheung, Christina Man-Tung
    Chan, Henry Lik-Yuen
    [J]. ANTIVIRAL THERAPY, 2013, 18 (05) : 671 - 679
  • [45] Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B
    Park, Joo Han
    Ahn, Seon Joo
    Cho, Hyo Jung
    Kim, Soon Sun
    Cheong, Jae Youn
    Cho, Sung Won
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (02) : 252 - 259
  • [46] Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
    Zoutendijk, Roeland
    Reijnders, Jurrien G. P.
    Zoulim, Fabien
    Brown, Ashley
    Mutimer, David J.
    Deterding, Katja
    Hofmann, Wolf Peter
    Petersen, Joerg
    Fasano, Massimo
    Buti, Maria
    Berg, Thomas
    Hansen, Bettina E.
    Sonneveld, Milan J.
    Wedemeyer, Heiner
    Janssen, Harry L. A.
    [J]. GUT, 2013, 62 (05) : 760 - 765
  • [47] Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir
    Yuan, Gui-Cai
    Chen, Ai-Zhen
    Wang, Wei-Xin
    Yi, Xu-Lan
    Tu, Long
    Peng, Fang
    Qiu, Zhi-Hong
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (34) : 8139 - 8146
  • [48] Correlation Between Serum Entecavir Concentration and Virological Response in Patients with Chronic Type B Hepatitis
    Wu, Zhengjie
    Gong, Yiwen
    Peng, Jun
    Zhang, Xiao
    Tang, Lingling
    [J]. MEDICAL SCIENCE MONITOR, 2019, 25 : 6998 - 7004
  • [49] EFFICACY OF PROLONGED TENOFOVIR MONOTHERAPY FOR PARTIAL VIROLOGIC RESPONSE TO TENOFOVIR IN TREATMENT-NAIVE CHRONIC HEPATITIS B PATIENTS
    Kim, B. S.
    Kim, M. K.
    Kang, S. M.
    Kim, S. H.
    Song, J. E.
    Kim, G. Y.
    Baek, S. A.
    Lee, C. H.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S509 - S509
  • [50] Long term clinical outcome in chronic hepatitis B patients with partial virologic response to entecavir treatment
    Chung, Kyu Sik
    Lee, Hye Won
    Park, Jun Yong
    Ku, Hye Jin
    Kim, Beom Kyung
    Kim, Seung Up
    Kim, Do Young
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    [J]. HEPATOLOGY, 2015, 62 : 970A - 970A
12345